81
IGF2-TRAP_Cancer
Oxford University
Peptide
Oncology
Target Identification or Validation
Researchers at the University of Oxford have identified key mutations that increase the affinity of Insulin-like Growth Factor 2 Receptor (IGFR2) for its ligand, reducing hypoglycaemia and tumour volume.
PCT-EP2016-068904